Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CD2-H82E7 | Human | Biotinylated Human Nectin-2 / CD112 Protein, His,Avitag™ (MALS verified) |  |
|
|
| CD2-H82A3 | Human | Biotinylated Human Nectin-2 / CD112 Protein, Mouse IgG2a Fc,Avitag™ (MALS verified) |  |
|
|
| CD2-H5257 | Human | Human Nectin-2 / CD112 Protein, Mouse IgG2a Fc Tag |  |
|
|
| CD2-H82F8 | Human | Biotinylated Human Nectin-2 / CD112 Protein, Fc,Avitag™ (HPLC verified) |  |
|
|
| PV2-H5253 | Human | Human Nectin-2 / CD112 Protein, Fc Tag |  |
|
|
| PV2-H52E2 | Human | Human Nectin-2 / CD112 Protein, His Tag |  |
|
|
Loaded Human Nectin-2, Mouse IgG2a Fc Tag (Cat. No. CD2-H5257) on Protein A Biosensor, can bind Human PVRIG, His Tag (Cat. No. PVG-H52H4) with an affinity constant of 1.33 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| COM-701 | COM-701 | Phase 2 Clinical | Compugen Ltd | Solid tumours; Head and Neck Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Lung Neoplasms | Details |
| PM-1009 | PM1009 | Phase 2 Clinical | Liver Neoplasms; Solid tumours; Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular | Details | |
| SIM-0348 | SIM-0348 | Phase 1 Clinical | Simcere Pharmaceutical Group Ltd | Solid tumours; Neoplasms | Details |
| GSK-4381562 | SRF-813; GSK-4381562; GSK-4381562A; GSK4381562A | Phase 1 Clinical | Surface Oncology Inc | Solid tumours; Neoplasms | Details |
| NM1F | NM1F; TGI-2 | Phase 1 Clinical | Hefei TG ImmunoPharma Co Ltd | Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Melanoma | Details |
| SHR-2002 | SHR-2002 | Phase 1 Clinical | Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Neoplasms | Details |
| JS-009 | JS009; TAB009; JS-009 | Phase 1 Clinical | Shanghai Junshi Biosciences Co Ltd | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
